CTMP, a predictive biomarker for trastuzumab resistance in HER2-enriched breast cancer patient.

Oncotarget · 2017 · PMC5444696 · PMID 27447863

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Patients with young age and later stages tend to have high expression of CTMP, but this difference did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.